HMDN
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Heramed Limited
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
3
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Heramed Limited - Ordinary Fully Paid Deferred
π Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in HMDN
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in HMDN
N/A
HMDN investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in HMDN also invest in...
HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusβ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
π Performance (5Yr p.a)
-15.71%
π Share price
$0.01 AUD
π©Ί HEALTH CARE
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
19.14%
π Share price
$134.81 AUD
π€ TECHNOLOGY
π GLOBAL
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
7.32%
π Share price
$96.95 AUD
π¦πΊ AUSTRALIA
β³οΈ DIVERSIFIED
𧱠MATERIALS
π HIGH PRICE GROWTH
πΈ FINANCIALS
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6817.34m in AUM and 201 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
π Performance (5Yr p.a)
8.07%
π Share price
$130.63 AUD
π¦πΊ AUSTRALIA
πΈ FINANCIALS
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Magellan Financial Group Ltd. engages in the provision of funds management services. The company is headquartered in Sydney, New South Wales and currently employs 109 full-time employees. The company went IPO on 2004-07-01. The Companyβs segments include Funds Management, Fund Investments and Associate Investments. The Funds Management segment provides investment fund management services to high net worth and retail investors in Australia and New Zealand, and to institutional investors globally. Its Funds Management activities include providing investment research and administrative services to certain clients; providing investment management and sub-advisory services under client mandates, and acting as responsible entity/trustee (RE) and/or investment manager (IM) for the funds (collectively the Magellan Funds). The Fund Investments segment comprises its direct investment in certain Magellan Funds and a select portfolio of listed Australian and international equities. The Associate Investments segment comprises a portfolio of selective investments in businesses in which it has a strategic interest.
π Performance (5Yr p.a)
-16.39%
π Share price
$7.74 AUD
π° HIGH DIVIDEND
πΈ FINANCIALS
Want more shares? Try these...
HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusβ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
π Performance (5Yr p.a)
-15.71%
π Share price
$0.01 AUD
π©Ί HEALTH CARE